Pirkko L. Harkonen

Turku, 20521, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles.

Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles.

Journal: Nanomedicine (London, England)

Published: October 09, 2024

Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models.

Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models.

Journal: Cancer medicine

Published: June 06, 2024

Targeting sex steroid biosynthesis for breast and prostate cancer therapy.

Targeting sex steroid biosynthesis for breast and prostate cancer therapy.

Journal: Nature reviews. Cancer

Published: July 20, 2023

Fluorescent Molecularly Imprinted Polymer Layers against Sialic Acid on Silica-Coated Polystyrene Cores-Assessment of the Binding Behavior to Cancer Cells.

Fluorescent Molecularly Imprinted Polymer Layers against Sialic Acid on Silica-Coated Polystyrene Cores-Assessment of the Binding Behavior to Cancer Cells.

Journal: Cancers

Published: March 01, 2022

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.

Journal: Cancers

Published: November 25, 2021

Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum.

Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum.

Journal: Cancer reports (Hoboken, N.J.)

Published: April 12, 2021

Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.

Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 17, 2020

Critical evaluation of the subcutaneous engraftments of hormone naïve primary prostate cancer.

Critical evaluation of the subcutaneous engraftments of hormone naïve primary prostate cancer.

Journal: Translational andrology and urology

Published: July 18, 2020

Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model.

Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model.

Journal: Journal of bone oncology

Published: January 08, 2019

SERMs Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells.

SERMs Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells.

Journal: Inflammation

Published: March 26, 2018

Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice.

Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice.

Journal: British journal of cancer

Published: April 12, 2017

Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells.

Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells.

Journal: Oncotarget

Published: March 13, 2017

Showing 1-12 of 38

Last Updated: 09/26/2026